Effect of radiographic & histopathologic variants in management of ameloblastoma

An original research

https://doi.org/10.53730/ijhs.v6nS6.9912

Authors

  • Bharathiram Guduri Senior lecturer, Dept. of Oral & MaxilloFacial Surgery, GSL Dental College, Rajahmundry
  • Shraddha C. Jugade Assistant Professor, Oral Medicine and Radiology, Dr. D Y Patil Dental College & Hospital, Dr. D Y Patil Vidyapeeth, Pimpri, Pune
  • Saurabh Shekhar Lecturer, Oral pathology, AIMST University, Bedong, Kedah, Malaysia
  • A. Rashmi Pillai MDS, Oral and Maxillofacial Surgeon, Rashmis Dentofacial Multispeciality Centre, Kavanad, Kollam, Kerala
  • Ankita Sharma Senior Lecturer, Dept of Pathology, NIMS Jaipur
  • Amrita Das Senior lecturer, Department of Periodontology and Implantology, Dr. HSRSM dental college , Hingoli. Maharashtra, India

Keywords:

ameloblastoma, management, radiographic, histologic features

Abstract

Introduction: Ameloblastoma is a rare, benign odontogenic tumor that accounts for 1% of all tumors of the jaws. We aim to compare the ameloblastoma recurrence rate according to the type of treatment: radical or conservative and as per the radiographic, histologic features. Material and methods: we conducted a retrospective study and collected the data based on the radiological, and histological and the type of treatment: conservative or radical and to compare the recurrence rate according to the type of treatment. Results: Thirty Patients were included, managed by conservative treatment (CT) in 26 cases and radical treatment (RT) in 14 cases. The recurrence rate was 90.9% in the CT group and 9.1% in the RT group (P = 0.025) with a mean follow-up of 56.2 months. Conclusion: The recurrence rate after conservative treatment was higher than that after radical treatment. The choice of treatment must be adapted to the macroscopic and histological characteristics of each tumor and to the patient.

Downloads

Download data is not yet available.

References

Olaitan AA, Adeola DS, Adekeye EO. Ameloblastoma: clinical features and management of 315 cases from Kaduna. Nigeria J Craniomaxillofac Surg 1993;21:351–5.

Nakamura N, Higuchi Y, Mitsuyasu T, Sandra F, Ohishi M. Comparison of long- term results between different approaches to ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:13–20.

Hong J, Yun PY, Chung IH, et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg 2007;36:283–8.

Hertog D, van der Waal I. Ameloblastoma of the jaws: a critical reappraisal based on a 40-years single institution experience. Oral Oncol 2010;46:61–4.

Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 1995;31:86–99.

Ruhin-Poncet B, Bouattour A, Picard A, Menard P, Capron F, Bertrand JC. Ameloblastoma of the jaws. A retrospective analysis from 1994 to 2007. Rev Stomatol Chir Maxillofac 2011;112:269–79.

Huang IY, Lai ST, Chen CH, Chen CM, Wu CW, Shen YH. Surgical management of ameloblastoma in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:478–85.

Carlson ER, Marx RE. The ameloblastoma: primary, curative surgical manage- ment. J Oral Maxillofac Surg 2006;64:484–94.

Huvos AG, Woodard AR, Cahan WG, et al. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer 1985;55:1244.

Sauk JJ, Nikitakis NG, Scheper MA. Are we on the brink of nonsurgical treat- ment for ameloblastoma? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:68–78.

Dissanayake RK, Jayasooriya PR, Siriwardena DJ, Tilakaratne WM. Review of metastasizing (malignant) ameloblastoma (METAM): pattern of metastasis and treatment. Med Oral Pathol Oral Radiol Endod 2011;111:734–41 [ER].

Kurppa KJ, Catón J, Morgan PR, Ristimäki A, et al. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol 2014;232:492–8.

Ricard AS, Majoufre-Lefebvre C, Siberchicot F, Laurentjoye M. A multirecur- rent ameloblastoma metastatic to the lung. Rev Stomatol Chir Maxillofac 2010;111:98–100.

Slootweg PJ, Müller H. Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol 1984;57:168–76.

Nastri AL, Wiesenfeld D, Radden BG, Eveson J, Scully C. Maxillary ameloblas- toma: a retrospective study of 13 cases. Br J Oral Maxillofac Surg 1995;33:28–32.

Kustina, K.T., Dewi, G.A.A.O., Prena, G.D., Suryasa, W. (2019). Branchless banking, third-party funds, and profitability evidence reference to banking sector in indonesia. Journal of Advanced Research in Dynamical and Control Systems, 11(2), 290-299.

Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202

Ermatov, N. J. ., & Abdulkhakov, I. U. . (2021). Socio-hygienic assessment of the incidence rate among various strata of the population-based on the materials of appeals and in-depth medical examinations. International Journal of Health & Medical Sciences, 4(3), 309-314. https://doi.org/10.31295/ijhms.v4n3.1758

Published

29-06-2022

How to Cite

Guduri, B., Jugade, S. C., Shekhar, S., Pillai, A. R., Sharma, A., & Das, A. (2022). Effect of radiographic & histopathologic variants in management of ameloblastoma: An original research. International Journal of Health Sciences, 6(S6), 1763–1769. https://doi.org/10.53730/ijhs.v6nS6.9912

Issue

Section

Peer Review Articles

Most read articles by the same author(s)